Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCCP, MRCP (UK), DTCD, MCPS
Neurologist
MBBS, FCPS (Medicine), FCPS (Neurology)
Gastroenterologist
MBBS, FCPS Gastroenterology
Diabetologist
MBBS, MCPS (Family Medicine), MRCGP
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Gastroenterologist
M.B.B.S., F.C.P.S.
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Internal Medicine Specialist
MBBS, Diplomate American Board Internal Medicine, Diplomate American Board Endocrinology, Diabetes & Metabolism
Internal Medicine Specialist
MBBS, Diplomate American Board Internal Medicine, Diplomate American Board Endocrinology, Diabetes & Metabolism
Asthma Specialist
MBBS, MRCP (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures